Book a demo
Research & KnowledgeEvent: September 3, 2026

Johnson & Johnson MedTech published a summary detailing the INHANCE INTACT™ Tissue Sparing Surgical Technique as a stemless-first approach for anatomic total shoulder arthroplasty.

Published

Signal category

Research & Knowledge

Quote

The INHANCE INTACT™ Tissue Sparing Surgical Technique is a stemless-first approach designed for anatomic total shoulder arthroplasty.

Lawrence "J.R." Manuel|Johnson & Johnson MedTech team

Company

Industry
Hospitals and Health Care
Location
New Brunswick, US
Company size
38,074 employees

At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. With deep expertise in surgery, orthopaedics, cardiovascular, and vision, we design healthcare solutions that are smarter, less invasive and more personalized. We are developing the next generation of med tech solutions to tackle the most pervasive and complex health challenges for people around the world. Community Guidelines: http://www.jnj.com/social-media-community-guidelines

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.